5-170252350-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The ENST00000524171.5(C5orf58):c.*695C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.483 in 733,698 control chromosomes in the GnomAD database, including 88,359 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.43 ( 15311 hom., cov: 32)
Exomes 𝑓: 0.50 ( 73048 hom. )
Consequence
C5orf58
ENST00000524171.5 3_prime_UTR
ENST00000524171.5 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.45
Genes affected
C5orf58 (HGNC:37272): (chromosome 5 open reading frame 58)
LCP2 (HGNC:6529): (lymphocyte cytosolic protein 2) This gene encodes an adapter protein that acts as a substrate of the T cell antigen receptor (TCR)-activated protein tyrosine kinase pathway. The encoded protein associates with growth factor receptor bound protein 2, and is thought to play a role TCR-mediated intracellular signal transduction. A similar protein in mouse plays a role in normal T-cell development and activation. Mice lacking this gene show subcutaneous and intraperitoneal fetal hemorrhaging, dysfunctional platelets and impaired viability. [provided by RefSeq, Nov 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 5-170252350-C-T is Benign according to our data. Variant chr5-170252350-C-T is described in ClinVar as [Benign]. Clinvar id is 2688122.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.517 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LCP2 | NM_005565.5 | c.1323+84G>A | intron_variant | ENST00000046794.10 | NP_005556.1 | |||
LCP2 | XM_047417171.1 | c.1092+84G>A | intron_variant | XP_047273127.1 | ||||
C5orf58 | NR_131091.3 | n.904C>T | non_coding_transcript_exon_variant | 4/4 | ||||
C5orf58 | NR_131092.3 | n.820C>T | non_coding_transcript_exon_variant | 3/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
C5orf58 | ENST00000524171.5 | c.*695C>T | 3_prime_UTR_variant | 4/4 | 1 | ENSP00000490552 | ||||
LCP2 | ENST00000046794.10 | c.1323+84G>A | intron_variant | 1 | NM_005565.5 | ENSP00000046794 | P1 | |||
LCP2 | ENST00000521416.5 | c.708+84G>A | intron_variant | 2 | ENSP00000428871 |
Frequencies
GnomAD3 genomes AF: 0.433 AC: 65820AN: 151894Hom.: 15295 Cov.: 32
GnomAD3 genomes
AF:
AC:
65820
AN:
151894
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.496 AC: 288588AN: 581686Hom.: 73048 Cov.: 8 AF XY: 0.499 AC XY: 153363AN XY: 307148
GnomAD4 exome
AF:
AC:
288588
AN:
581686
Hom.:
Cov.:
8
AF XY:
AC XY:
153363
AN XY:
307148
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.433 AC: 65872AN: 152012Hom.: 15311 Cov.: 32 AF XY: 0.429 AC XY: 31914AN XY: 74310
GnomAD4 genome
AF:
AC:
65872
AN:
152012
Hom.:
Cov.:
32
AF XY:
AC XY:
31914
AN XY:
74310
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1706
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Jan 24, 2024 | This variant is classified as Benign based on local population frequency. This variant was detected in 51% of patients studied by a panel of primary immunodeficiencies. Number of patients: 48. Only high quality variants are reported. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at